Key facts
- TuneMe’s last known valuation is $2.8M (Jan 2025).
- It has raised $810K; the latest was Seed Round ($810K) in Jan 2025.
- Notable investors include eHealth Ventures (Israel).
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for TuneMe
- ·The full record, as it builds
Funding rounds
No funding rounds for TuneMe are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About TuneMe
Developer of a personalized digital therapy platform designed for promoting mental wellness and better rest. The company's platform uses artificial intelligence to analyze an individual's vocal stress signals in real-time, subsequently generating a unique vibroacoustic audio session by selecting tailored frequencies, enabling individuals and care networks to access tailored stress reduction and sleep support.
- Sector
- Healthcare
- HQ
- Tel Aviv, Israel
- Founded
- 2020
- Employees
- 4
- Website
- tuneme.io/
- Ownership
- Privately Held (backing)
TuneMe doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in TuneMe shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on TuneMe in its N-PORT filings yet. We sweep new filings monthly.